Medicare Negotiations: Implications to Non-Medicare Plans

This webinar featured an engaging discussion with Rachel Alexander and Theresa Carnegie, Mintz and Hiram Satterwhite and Andrew Timcheck, Milliman. They provided an overview of CMS’s drug negotiations and the recent announcement of negotiated products for the 2026 Medicare Program and discussed the key legal and financial implication and considerations for non-Medicare payers and pharmacies.

Watch the webinar here: